Our recently published study on adherence to lipid-lowering drugs was featured in a newspaper article in Dagens Medisin. Our study tracks all patients in Norway who initiated treatment with proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9 mAbs) from 2015 to 2023.
Health and life science
Stroke management in atrial fibrillation patients with rheumatoid arthritis
In collaboration with REMEDY-Centre for Treatment of Rheumatic and Musculoskeletal Diseases at Diakonhjemmet hospital, we have published an article investigating stroke management in atrial fibrillation patients with rheumatoid arthritis. The investigation relies on Norwegian registry data from hospitals and pharmacies.
International experiences with primary health care teams
This week, Oslo Economics participated in a research workshop on international experiences with primary health care teams, together with researchers from Norway, France, Germany, and Canada.
Evaluation of measures in primary healthcare services
On behalf of the Norwegian Directorate of Health, Oslo Economics and the University of Oslo, in collaboration with several subject matter experts, are conducting a follow-up evaluation of measures in primary healthcare services. This year’s evaluation shows that the situation for general practitioners appears to have improved, while there are still significant challenges related to the population’s access to general medical services.
Analysis of the marginal costs of activity growth in the Norwegian specialist health service
Oslo Economics, in collaboration with Sverre Kittelsen (Frisch Centre), Kjartan Sarheim Anthun (SINTEF) and Jon Magnussen (NTNU), has calculated the marginal costs associated with increasing the activity levels in the Norwegian specialist health service. The study is part of the foundation for the Norwegian government’s recently announced healthcare plan and has been conducted on the behalf of the Ministry of Health and Care Services.
The proposal from the Abortion Committee will provide an increased degree of reproductive freedom for women.
On behalf of the Abortion Committee, Oslo Economics has assessed the economic consequences of the committee’s proposed changes to the abortion law, as well as other measures related to improved information, increased competence in healthcare services, and more knowledge about abortion in Norway.
Does primary health care teams contribute to better health care services for patients at the general practitioner offices?
Since April 2018, a total of 17 general practitioner (GP) offices have participated in a pilot project with primary health care teams (PHT) and two alternative financing schemes. Results from the pilot study indicate that GP offices experience that PHT offer new solutions to their challenges, and further that most patients were satisfied with the follow-up and would like to continue with nurse consultations
Oslo Economics’ work provides knowledge for important decisions
Our work is now part of The Official Norwegian Report NOU2023:4 Tid for handling, which was published by the Ministry og Health and Care Services this week.
The proposal of a special compensation scheme to the “oil pioneers”
“Oil pioneers” have suffered health damages after being exposed to chemicals and toxic materials during their work offshore. A commission is now set up to create a compensation scheme for these pioneers.
Potential for improvement in treatment of lipid lowering drugs
Do patients take medication as prescribed or is there a potential for improvement?
Oslo Economics have presented their ongoing study on myasthenia gravis in the U.S. and Denmark
Oslo Economics, UCB Pharma and the University of Bergen are currently collaborating on a research project about the societal costs of myasthenia in Norway.
How can we motivate seniors to stay longer in their health care professions?
On behalf of The Norwegian Directorate of Health, Oslo Economics will investigate work participation among seniors in the health care sector.
